by LyfeSci Clinical Developmenton November 02• 45 min webinar
Topics
Phase 1
Clinical Development
Designing Phase 1 studies that scale
How to build early-phase studies that support Phase 2 endpoints and commercialization planning.
Learn how to align early design with long-term program goals.
Key takeaways
- Design dose escalation with Phase 2 proof points in mind.
- Create adaptable protocols that preserve timing.
- Use early data to de-risk regulatory engagement.
This session features practical frameworks from LyfeSci experts who support complex early-phase programs.
Ready to apply these insights?
LyfeSci partners with sponsors to translate strategy into execution, from early planning through late-stage delivery.